iBio (IBIO) Total Current Liabilities (2016 - 2025)
Historic Total Current Liabilities for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to $5.9 million.
- iBio's Total Current Liabilities rose 2531.32% to $5.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.9 million, marking a year-over-year increase of 2531.32%. This contributed to the annual value of $6.1 million for FY2025, which is 5901.04% up from last year.
- iBio's Total Current Liabilities amounted to $5.9 million in Q4 2025, which was up 2531.32% from $6.0 million recorded in Q3 2025.
- iBio's Total Current Liabilities' 5-year high stood at $32.2 million during Q3 2022, with a 5-year trough of $3.5 million in Q3 2024.
- Over the past 5 years, iBio's median Total Current Liabilities value was $8.2 million (recorded in 2021), while the average stood at $13.6 million.
- Per our database at Business Quant, iBio's Total Current Liabilities surged by 35802.86% in 2022 and then plummeted by 8324.8% in 2024.
- Quarter analysis of 5 years shows iBio's Total Current Liabilities stood at $8.3 million in 2021, then soared by 232.79% to $27.8 million in 2022, then decreased by 22.4% to $21.6 million in 2023, then plummeted by 78.15% to $4.7 million in 2024, then grew by 25.31% to $5.9 million in 2025.
- Its Total Current Liabilities was $5.9 million in Q4 2025, compared to $6.0 million in Q3 2025 and $6.1 million in Q2 2025.